- Home
- GRCE vs ICMB Comparison
GRCE vs ICMB Comparison
Compare GRCE & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- ICMB
- Stock Information
- Founded
- GRCE 2002
- ICMB 2012
- Country
- GRCE United States
- ICMB United States
- Employees
- GRCE N/A
- ICMB N/A
- Industry
- GRCE
- ICMB Finance: Consumer Services
- Sector
- GRCE
- ICMB Finance
- Exchange
- GRCE NYSE
- ICMB Nasdaq
- Market Cap
- GRCE 40.0M
- ICMB 41.1M
- IPO Year
- GRCE N/A
- ICMB N/A
- Fundamental
- Price
- GRCE $3.00
- ICMB $2.85
- Analyst Decision
- GRCE Strong Buy
- ICMB
- Analyst Count
- GRCE 1
- ICMB 0
- Target Price
- GRCE $12.00
- ICMB N/A
- AVG Volume (30 Days)
- GRCE 40.7K
- ICMB 36.7K
- Earning Date
- GRCE 08-15-2025
- ICMB 05-13-2025
- Dividend Yield
- GRCE N/A
- ICMB 16.78%
- EPS Growth
- GRCE N/A
- ICMB N/A
- EPS
- GRCE N/A
- ICMB 0.82
- Revenue
- GRCE N/A
- ICMB $20,996,189.00
- Revenue This Year
- GRCE N/A
- ICMB N/A
- Revenue Next Year
- GRCE N/A
- ICMB N/A
- P/E Ratio
- GRCE N/A
- ICMB $3.42
- Revenue Growth
- GRCE N/A
- ICMB N/A
- 52 Week Low
- GRCE $1.75
- ICMB $2.46
- 52 Week High
- GRCE $4.97
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- ICMB 52.61
- Support Level
- GRCE N/A
- ICMB $2.75
- Resistance Level
- GRCE N/A
- ICMB $3.00
- Average True Range (ATR)
- GRCE 0.00
- ICMB 0.09
- MACD
- GRCE 0.00
- ICMB 0.01
- Stochastic Oscillator
- GRCE 0.00
- ICMB 58.82
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.